Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v3-EN
Language French English
Date Updated 2024-04-01 2024-04-01
Drug Identification Number 02212153 02212153
Brand name IMITREX DF - TAB 50MG IMITREX DF - TAB 50MG
Common or Proper name Sumatriptan succinate tablets Sumatriptan succinate tablets
Company Name GLAXOSMITHKLINE INC GLAXOSMITHKLINE INC
Ingredients SUMATRIPTAN SUMATRIPTAN
Strength(s) 50MG 50MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 6s 6s
ATC code N02CC N02CC
ATC description ANTIMIGRAINE PREPARATIONS ANTIMIGRAINE PREPARATIONS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-12-21 2023-12-21
Estimated end date Unknown Unknown
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments